title: Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
abstract: The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with preinvasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity using ASCUS+ or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities using ASCUS+ or LSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity using ASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity using ASCUS+ or LSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, or HSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
authors: From the Department of Gynaecology, West China Second University Hospital (KL, RY), Sichuan University, Chengdu, Sichuan, China.
authors: Kemin
authors: K
authors: Li
authors: Rutie
authors: R
authors: Yin
mesh_terms: D000328:Adult; D000368:Aged; D065309:Atypical Squamous Cells of the Cervix; D002681:China; D003127:Colposcopy; D004279:DNA, Viral; D005260:Female; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D016017:Odds Ratio; D065006:Papanicolaou Test; D030361:Papillomavirus Infections / Q000175:diagnosis*; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000473:pathology / Q000821:virology
chemical_list: D004279:DNA, Viral
references: J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88
references: 20841605
references: Int J Cancer. 2006 Dec 1;119(11):2677-84
references: 16991121
references: Eur J Cancer. 2008 Mar;44(4):565-71
references: 18248809
references: JAMA. 1999 May 5;281(17):1605-10
references: 10235153
references: Pathol Annu. 1973;8:301-28
references: 4583016
references: Arch Pathol Lab Med. 2003 Sep;127(9):1169-75
references: 12946228
references: CMAJ. 2000 Sep 19;163(6):701-7
references: 11022584
references: Obstet Gynecol. 1998 Jun;91(6):973-6
references: 9611007
references: JAMA. 2002 Apr 24;287(16):2120-9
references: 11966387
references: JAMA. 2002 Apr 24;287(16):2114-9
references: 11966386
references: J Natl Cancer Inst. 2010 Mar 3;102(5):315-24
references: 20157096